|
|
||||||||
American Journal of Clinical Nutrition, Vol 63, 741-745, Copyright © 1996 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
R Shoda, K Matsueda, S Yamato and N Umeda
Division of Gastroenterology, International Medical Center of Japan, Tokyo.
We examined the correlation between the incidence of Crohn disease and dietary change in a relatively homogeneous Japanese population. The incidence and daily intake of each dietary component were compared annually from 1966 to 1985. The univariate analysis showed that the increased incidence of Crohn disease was strongly (P < 0.001) correlated with increased dietary intake of total fat (r = 0.919). animal fat (r = 0.880), n-6 polyunsaturated fatty acids (r = 0.883), animal protein (r = 0.908), milk protein (r = 0.924), and the ratio of n-6 to n-3 fatty acid intake (r = 0.792). It was less correlated with intake of total protein (r = 0.482, P < 0.05), was not correlated with intake of fish protein (r = 0.055, P > 0.1), and was inversely correlated with intake of vegetable protein (r = -0.941, P < 0.001). The multivariate analysis showed that increased intake of animal protein was the strongest independent factor with a weaker second factor, an increased ration of n-6 to n-3 polyunsaturated fatty acids. The present study in association with reported clinical studies suggests that increased dietary intake of animal protein and n-6 polyunsaturated fatty acids with less n-3 polyunsaturated fatty acids may contribute to the development of Crohn disease.
This article has been cited by other articles:
![]() |
C. N Bernstein and F. Shanahan Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases Gut, September 1, 2008; 57(9): 1185 - 1191. [Full Text] [PDF] |
||||
![]() |
M. Issa and D. G. Binion Bowel Rest and Nutrition Therapy in the Management of Active Crohn's Disease Nutr Clin Pract, June 1, 2008; 23(3): 299 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Biasi, C. Mascia, and G. Poli The contribution of animal fat oxidation products to colon carcinogenesis, through modulation of TGF-{beta}1 signaling Carcinogenesis, May 1, 2008; 29(5): 890 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Colombel, A. J M Watson, and M. F Neurath The 10 remaining mysteries of inflammatory bowel disease Gut, April 1, 2008; 57(4): 429 - 433. [Full Text] [PDF] |
||||
![]() |
S. J. Shin and M. T. Collins Thiopurine Drugs Azathioprine and 6-Mercaptopurine Inhibit Mycobacterium paratuberculosis Growth In Vitro Antimicrob. Agents Chemother., February 1, 2008; 52(2): 418 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Bush, J. M. Havens, B. M. Necela, W. Su, L. Chen, M. Yanagisawa, P. Z. Anastasiadis, R. Guerra, B. A. Luxon, and E. A. Thompson Functional Genomic Analysis Reveals Cross-talk between Peroxisome Proliferator-activated Receptor {gamma} and Calcium Signaling in Human Colorectal Cancer Cells J. Biol. Chem., August 10, 2007; 282(32): 23387 - 23401. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Abubakar, D. J. Myhill, A. R. Hart, I. R. Lake, I. Harvey, J. M. Rhodes, R. Robinson, A. J. Lobo, C. S. J. Probert, and P. R. Hunter A Case-Control Study of Drinking Water and Dairy Products in Crohn's Disease--Further Investigation of the Possible Role of Mycobacterium avium paratuberculosis Am. J. Epidemiol., April 1, 2007; 165(7): 776 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Hudert, K. H. Weylandt, Y. Lu, J. Wang, S. Hong, A. Dignass, C. N. Serhan, and J. X. Kang Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis PNAS, July 25, 2006; 103(30): 11276 - 11281. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C Calder n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1505 - 1519S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H MacLean, W. A Mojica, S. J Newberry, J. Pencharz, R. H. Garland, W. Tu, L. G Hilton, I. M Gralnek, S. Rhodes, P. Khanna, et al. Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease Am. J. Clinical Nutrition, September 1, 2005; 82(3): 611 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jacobson, H. Mundra, and S. M. Innis Intestinal responsiveness to experimental colitis in young rats is altered by maternal diet Am J Physiol Gastrointest Liver Physiol, July 1, 2005; 289(1): G13 - G20. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Gassull, J. Mane, E. Pedrosa, and E. Cabre Macronutrients and Bioactive Molecules: Is There a Specific Role in the Management of Inflammatory Bowel Disease? JPEN J Parenter Enteral Nutr, July 1, 2005; 29(4_suppl): S179 - S183. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Sood, V Midha, N Sood, A S Bhatia, and G Avasthi Incidence and prevalence of ulcerative colitis in Punjab, North India Gut, November 1, 2003; 52(11): 1587 - 1590. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nieto, M. I. Torres, A. Rios, and A. Gil Dietary Polyunsaturated Fatty Acids Improve Histological and Biochemical Alterations in Rats with Experimental Ulcerative Colitis J. Nutr., January 1, 2002; 132(1): 11 - 19. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |